FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 6 L

MDR report key: 12015486 · Received June 17, 2021

Report

Report Number
3005180920-2021-00499
Event Type
Injury
Date Received
June 17, 2021
Date of Event
May 19, 2021
Report Date
June 17, 2021
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030825873
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 27 MAY 2021: LOT 1901829: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 28-JUNE-2019. EXPIRATION DATE: 2024-06-16. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL IMPLANT INVOLVED: GMK-SPHERE 02.07.1205L TIBIAL TRAY FIXED CEMENTED SIZE 5 L (K090988) LOT. 1903537. BATCH REVIEW PERFORMED ON 27 MAY 2021: LOT 1903537: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 03-OCT-2019. EXPIRATION DATE: 2024-09-17. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL IMPLANT INVOLVED: GMK-SPHERE 02.12.0511FL TIBIAL INSERT FIXED SPHERE FLEX SIZE 5/11 MM L (K140826) LOT. 183025. BATCH REVIEW PERFORMED ON 27 MAY 2021. LOT 183025: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 02-JULY-2018. EXPIRATION DATE: 2023-06-17. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

THE PATIENT CAME IN REPORTING STIFFNESS DURING FLEXION. THE SURGEON REVISED THE FEMORAL COMPONENT, TIBIAL TRAY AND POLY 1 YEAR 6 MONTHS AFTER THE PRIMARY AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
914862 GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 6 L CEMENTED FEMORAL COMPONENT JWH MEDACTA INTERNATIONAL SA 02.12.0006L 1901829 07630030825873

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention